Evidence Hub

Atypical Mycobacterium fortuitum Ulcer in an Immunosuppressed Patient With Lupus: A Case Report

Eaton AC, Patel RH, Longo MI

Cureus, 2026

Abstract

A 65-year-old woman with systemic lupus erythematosus (SLE) on methotrexate and prednisone presented to the dermatology clinic with a chronic, painful ulcer on the right lower leg. The initial differential diagnosis included pyoderma gangrenosum and vasculitis. However, biopsy and wound cultures ultimately revealed Mycobacterium fortuitum. The patient was treated successfully with moxifloxacin and trimethoprim-sulfamethoxazole for four months, resulting in complete ulcer resolution. This case highlights the importance of considering atypical mycobacterial infection in chronic non-healing ulcers, particularly in immunosuppressed patients, and demonstrates the need for early tissue cultures to guide appropriate antimicrobial therapy.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free